ClinicalTrials.govpublic full text
Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)
pulmonary disease, chronic obstructive, hcru exacerbations, sgrq, cxcr2 antagonist, gsk1325756, danirixin, copd, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 849097
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.